

[ Tue, Jun 25th 2024
] - WOPRAI
[ Tue, Jun 25th 2024
] - WOPRAI
[ Tue, Jun 25th 2024
] - WOPRAI
[ Tue, Jun 25th 2024
] - WOPRAI
[ Tue, Jun 25th 2024
] - WOPRAI
[ Tue, Jun 25th 2024
] - WOPRAI
[ Tue, Jun 25th 2024
] - WOPRAI
[ Tue, Jun 25th 2024
] - WOPRAI
[ Tue, Jun 25th 2024
] - WOPRAI
[ Tue, Jun 25th 2024
] - WOPRAI
[ Tue, Jun 25th 2024
] - WOPRAI
[ Tue, Jun 25th 2024
] - WOPRAI
[ Tue, Jun 25th 2024
] - WOPRAI

[ Mon, Jun 24th 2024
] - WOPRAI
[ Mon, Jun 24th 2024
] - WOPRAI
[ Mon, Jun 24th 2024
] - WOPRAI
[ Mon, Jun 24th 2024
] - WOPRAI
[ Mon, Jun 24th 2024
] - WOPRAI
[ Mon, Jun 24th 2024
] - WOPRAI
[ Mon, Jun 24th 2024
] - WOPRAI
[ Mon, Jun 24th 2024
] - WOPRAI
[ Mon, Jun 24th 2024
] - WOPRAI
[ Mon, Jun 24th 2024
] - WOPRAI
[ Mon, Jun 24th 2024
] - WOPRAI
[ Mon, Jun 24th 2024
] - WOPRAI
[ Mon, Jun 24th 2024
] - WOPRAI
[ Mon, Jun 24th 2024
] - WOPRAI
[ Mon, Jun 24th 2024
] - WOPRAI
[ Mon, Jun 24th 2024
] - WOPRAI
Andrew Fein Reiterated (AMLX) at Strong Buy and Held Target at $8 on, Jun 24th, 2024
Andrew Fein of HC Wainwright & Co., Reiterated "Amylyx Pharmaceuticals, Inc." (AMLX) at Strong Buy and Held Target at $8 on, Jun 24th, 2024.
Andrew has made no other calls on AMLX in the last 4 months.
There are 6 other peers that have a rating on AMLX. Out of the 6 peers that are also analyzing AMLX, 5 agree with Andrew's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Graig Suvannavejh of "Mizuho" Maintained at Hold with Decreased Target to $3 on, Tuesday, May 14th, 2024
- Joel Beatty of "Baird" Maintained at Hold with Decreased Target to $3 on, Thursday, April 11th, 2024
- Marc Goodman of "Leerink Partners" Downgraded from Buy to Hold on, Monday, March 11th, 2024
- Chris Shibutani of "Goldman Sachs" Downgraded from Strong Buy to Hold and Decreased Target to $4 on, Monday, March 11th, 2024
- Umer Raffat of "Evercore ISI Group" Downgraded from Buy to Hold on, Friday, March 8th, 2024
This is the rating of the analyst that currently disagrees with Andrew
- Neena Bitritto-Garg of "Deutsche Bank" Maintained at Strong Buy with Decreased Target to $8 on, Monday, March 11th, 2024
Contributing Sources